OTC: PMCUF - Pro Medicus Limited

Yield per half year: +70.42%

Share chart Pro Medicus Limited

Extended chart Simple chart
Financial Markets by TradingView

About

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software.

more details
It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Health Care Technology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0.4677
Дивиденд ао 0.2466
Сайт https://www.promed.com.au
Change price per week: -3.53% (163.775)
Change price per month: +5.33% (150)
Change price per 3 month: +31.67% (120)
Change price per half year: +70.42% (92.71)
Change price per year: +144.02% (64.75)
Change price per 3 year: +270.37% (42.66)
Change price per 5 year: +1 384.26% (10.645)
Change price per year to date: -0.0044% (158.007)
All parameters

Underestimation

Title Value Grade
P/S 92.7 1
P/BV 53.32 1
P/E 180.83 1
EV/EBITDA 123.33 1
Total: 1

Efficiency

Title Value Grade
ROA, % 28.2 8
ROE, % 39.47 9
Total: 9.33

Dividends

Title Value Grade
Div yield, % 0.4464 1.13
DSI 0.9286 9.29
Total: 5.24

Debt

Title Value Grade
Debt/EBITDA 0.025 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % 92.61 9
Yield Ebitda, % 116.52 10
Yield EPS, % 142.43 10
Total: 7.8
More

Dividend, % Dividend Result of period Buy before Register closing date Payment before
0.24% 0.15 II кв. 2024 02.09.2024 04.09.2024 19.09.2024
0.19% 0.12 IV кв. 2023 27.02.2024 29.02.2024 15.03.2024
More

Head Job title Payment Year of birth
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Executive Director 724.12k
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Executive Director 251.94k
Mr. Clayton James Hatch B.Comm, CPA, CPA Chief Financial Officer 279.15k
Dr. Malte Westerhoff GM of Europe & Global CTO 822.73k
Mr. Brad Levin GM of North America & Global Head of Marketing 261.78k
Ms. Sharni L. Redenbach People & Culture Director N/A
Mr. Sean Lambright Global Head of Sales - Visage Imaging Inc 801.7k
Ms. Teresa Gschwind Global Head of Customer Service of Visage Imaging Inc. N/A
Ms. Danny English C.A. Financial Controller & Company Secretary N/A

Address: Australia, Richmond. VIC, 450 Swan Street - open in Google maps, open in Yandex maps
Website: https://www.promed.com.au